|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-2-24
|
|
pubmed:abstractText |
The in vitro activity of the histatin derivative P-113, alone or combined with eight antibiotics, was investigated against multidrug-resistant strains isolated from clinical specimens of immunocompromised patients with pneumonia. The gram-negative isolates were susceptible to P-113. S. aureus showed less susceptibility. Synergy was demonstrated when P-113 was combined with beta-lactams against gram-negative organisms.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-10202312,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-10348745,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-10348756,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-10922046,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-11302797,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-11709321,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-11871492,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-11932230,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-14975505,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-15216473,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-2191922,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-3286634,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-3614352,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-8270032,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-9597250,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15728942-9825223
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1249-52
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15728942-Drug Resistance, Multiple, Bacterial,
pubmed-meshheading:15728942-Histatins,
pubmed-meshheading:15728942-Humans,
pubmed-meshheading:15728942-Immunocompromised Host,
pubmed-meshheading:15728942-Microbial Sensitivity Tests,
pubmed-meshheading:15728942-Pneumonia, Bacterial,
pubmed-meshheading:15728942-Pseudomonas aeruginosa,
pubmed-meshheading:15728942-Salivary Proteins and Peptides,
pubmed-meshheading:15728942-Staphylococcus aureus,
pubmed-meshheading:15728942-Stenotrophomonas maltophilia
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.
|
|
pubmed:affiliation |
Institute of Infectious Diseases and Public Health, Università Politecnica dell Marche, Ancona, Italy. anconacmi@interfree.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
